| 1 | [SID49679733] | Active | Potency | 0.5221 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 0.5221 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49679733] | Active | Potency | 2.0787 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 2.0787 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49679733] | Active | IC50 | 5.82 | Dose Response confirmation of UBC13 Polyubiquitin Inhibitors using a Bfl-1 counterscreen [AID504689, Type: confirmatory] | Bcl2a1a gene product [Mus musculus] [gi:11024684] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | IC50 | 5.82 [uM] | | BioAssay | Dose Response confirmation of UBC13 Polyubiquitin Inhibitors using a Bfl-1 counterscreen | | AID | 504689 | | BioAssay type | confirmatory | | Target | Bcl2a1a gene product [Mus musculus] [gi:11024684] | | PubMed | | | Data Table |  |
|
| 4 | [SID49679733] | Active | IC50 | 8.282 | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm [AID493182, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | IC50 | 8.282 [uM] | | BioAssay | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm | | AID | 493182 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 5 | [SID49679733] | Active | IC50 | 8.282 | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm [AID493182, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | IC50 | 8.282 [uM] | | BioAssay | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay reconfirm | | AID | 493182 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 6 | [SID49679733] | Active | IC50 | 9 | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID493155, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | IC50 | 9 [uM] | | BioAssay | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 493155 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 7 | [SID49679733] | Active | IC50 | 9 | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID493155, Type: confirmatory] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | IC50 | 9 [uM] | | BioAssay | Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 493155 | | BioAssay type | confirmatory | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 8 | [SID49679733] | Active | Potency | 9.5283 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 9.5283 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 9 | [SID49679733] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 10 | [SID49679733] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 11 | [SID49679733] | Active | Potency | 14.1254 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 12 | [SID49679733] | Active | Potency | 14.1254 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 13 | [SID49679733] | Active | Potency | 19.9526 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 14 | [SID49679733] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 15 | [SID49679733] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 16 | [SID49679733] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 17 | [SID49679733] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 18 | [SID49679733] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 19 | [SID49679733] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 20 | [SID49679733] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 21 | [SID49679733] | Active | Potency | 56.2341 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 22 | [SID49679733] | Active | Potency | 56.2341 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 23 | [SID49679733] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL) [AID2751, Type: screening] | Prolyl endopeptidase-like [Homo sapiens] [gi:153217451] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL) | | AID | 2751 | | BioAssay type | screening | | Target | Prolyl endopeptidase-like [Homo sapiens] [gi:153217451] | | PubMed | | | Data Table |  |
|
| 24 | [SID49679733] | Active | | | Single concentration confirmation of uHTS for APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493152, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493152 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 25 | [SID49679733] | Active | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 26 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) [AID651608, Type: screening] | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) | | AID | 651608 | | BioAssay type | screening | | Target | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] | | PubMed | | | Data Table |  |
|
| 27 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) [AID651572, Type: screening] | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) | | AID | 651572 | | BioAssay type | screening | | Target | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] | | PubMed | | | Data Table |  |
|
| 28 | [SID49679733] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 29 | [SID49679733] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 30 | [SID49679733] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 31 | [SID49679733] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 32 | [SID49679733] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 33 | [SID49679733] | Active | | | Single concentration confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID488859, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 488859 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 34 | [SID49679733] | Active | | | Single concentration confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID488859, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 488859 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 35 | [SID49679733] | Active | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 36 | [SID49679733] | Active | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 37 | [SID49679733] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 38 | [SID49679733] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 39 | [SID49679733] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 40 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 41 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 42 | [SID49679733] | Active | | | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID652036, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 652036 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID49679733] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID49679733] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID49679733] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 46 | [SID49679733] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 47 | [SID49679733] | Active | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 48 | [SID49679733] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 49 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 50 | [SID49679733] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624431, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49679733 | | CID | 22332182 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624431 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|